Constellation Brands has struck a defiant tone over the prospects of its US4bn investment in cannabis venture Canopy Growth Corp., despite the Canadian company’s poor financial performance and the lack of progress on US federal marijuana legalisation.
Constellation Brands defends Canopy Growth Corp cannabis venture
The group’s US$4bn 2018 investment is yet to pay off.